World Lifestyler
  • Art & Culture
    • Books & Literature
    • Cinema & Film
    • Design & Architecture
    • Exhibitions
    • Theatre
    • Music
  • Lifestyle
    • Fashion
    • Health & Fitness
    • Home & Living
    • Luxury Living
    • Car Reviews
    • Collectors
    • Luxury Cars
    • Planes
    • Private Jets
    • Yachts
  • Travel
    • Exclusives
    • Travel
      • Adventure & Tours
      • City Guides
      • Cruises
      • Holidays
      • Resorts & Spas
      • Reviews & Tips
    • Fashion Events
    • Festivals
    • Meetups
    • Outdoor Excursions
    • Road Trips
    • VIP Experiences
  • Food & Drink
    • Beers & Spirits
    • Chefs & Cooks
    • City Eating Guides
    • Fine Dining
    • Recipes
    • Restaurant Reviews
  • Tech
    • Audio
    • Gadgets
    • Gaming
    • Mobile
    • PCs
    • Reviews
    • VR/AR
    • Wearables
  • Art & Culture
    • Books & Literature
    • Cinema & Film
    • Design & Architecture
    • Exhibitions
    • Theatre
    • Music
  • Lifestyle
    • Fashion
    • Health & Fitness
    • Home & Living
    • Luxury Living
    • Car Reviews
    • Collectors
    • Luxury Cars
    • Planes
    • Private Jets
    • Yachts
  • Travel
    • Exclusives
    • Travel
      • Adventure & Tours
      • City Guides
      • Cruises
      • Holidays
      • Resorts & Spas
      • Reviews & Tips
    • Fashion Events
    • Festivals
    • Meetups
    • Outdoor Excursions
    • Road Trips
    • VIP Experiences
  • Food & Drink
    • Beers & Spirits
    • Chefs & Cooks
    • City Eating Guides
    • Fine Dining
    • Recipes
    • Restaurant Reviews
  • Tech
    • Audio
    • Gadgets
    • Gaming
    • Mobile
    • PCs
    • Reviews
    • VR/AR
    • Wearables
No Result
View All Result
World Lifestyler
No Result
View All Result
Home Lifestyle

VRNS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Varonis Systems (VRNS) Investors of Securities Class Action Deadline on March 9, 2026

Cision PR Newswire by Cision PR Newswire
February 28, 2026
in Lifestyle
Reading Time: 5 mins read
0
Share on FacebookShare on Twitter

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Varonis To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Varonis between February 4, 2025 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, Feb. 28, 2026 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Varonis Systems, Inc. (“Varonis” or the “Company”) (NASDAQ: VRNS) and reminds investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.


Faruqi & Faruqi, LLP (PRNewsfoto/Faruqi & Faruqi, LLP)

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Varonis’ ability to convert its existing customer base; notably, that it was not truly equipped to convince existing users of the benefits of converting to the SaaS offering or otherwise maintain those customers on its platform, resulting in significantly reduced ARR growth potential in the near-term. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Varonis’ securities at artificially inflated prices.

On October 28, 2025, Varonis announced its financial results for the third quarter of fiscal 2025, disclosing a significant miss to ARR and reducing its projections for the full fiscal year 2025, despite previously uplifting guidance for the previous two consecutive quarters. The Company attributed its results and lowered guidance on weaker than expected renewals and conversions in their federal and non-federal on-premises subscription business. Varonis further resultantly announced the end of life of the self-hosted solution and a 5% headcount reduction.

Following this news, Varonis’ common stock declined dramatically. From a closing market price of $63.00 per share on October 28, 2025, Varonis’ stock price fell to $32.34 per share on October 29, 2025, a decline of about 48.67% in the span of just a single day.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Varonis’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Varonis Systems class action, go to www.faruqilaw.com/VRNS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.


James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vrns-deadline-alert-faruqi–faruqi-llp-reminds-varonis-systems-vrns-investors-of-securities-class-action-deadline-on-march-9-2026-302699929.html

SOURCE Faruqi & Faruqi, LLP

Cision PR Newswire

Cision PR Newswire

Related Posts

Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis

February 28, 2026

SDM Deadline: SDM Investors with Losses in Excess of $100K Have Opportunity to Lead Smart Digital Group Ltd. Securities Fraud Lawsuit

February 28, 2026

AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

February 28, 2026

HUBG INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group

February 28, 2026

PSFE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Paysafe Limited (PSFE) Investors of Securities Class Action Deadline on April 7, 2026

February 28, 2026

AGL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026

February 28, 2026

Popular News

  • Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis

    0 shares
    Share 0 Tweet 0
  • SDM Deadline: SDM Investors with Losses in Excess of $100K Have Opportunity to Lead Smart Digital Group Ltd. Securities Fraud Lawsuit

    0 shares
    Share 0 Tweet 0
  • Richardson Paris Baguette Café to Open Feb. 27, 2026 as Brand Continues to Dominate the Bakery Café Space

    0 shares
    Share 0 Tweet 0
  • Well-grounded Confidence! How China’s domestic growth drivers propel a strong start to its 15th Five-Year Plan

    0 shares
    Share 0 Tweet 0
  • AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home
  • Business

© 2025 World Lifestyler